Related Experiment Videos
Mantle cell lymphomas lack expression of p27Kip1, a cyclin-dependent kinase inhibitor
L Quintanilla-Martinez1, C Thieblemont, F Fend
1Hematopathology Section, Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
Abstract:
p27Kip1 is a cyclin-dependent kinase inhibitor that regulates the decision to enter S phase or withdraw from the cell cycle. In resting cells, the level of p27Kip1 provides an inhibitory threshold above which G1 cyclin D/E/cyclin-dependent kinases accumulate before activation; however, in cycling cells, p27Kip1 protein is sequestered by high levels of active cyclin D/cyclin-dependent kinase 4 complexes. As a group, the cyclin-dependent kinase inhibitors have been proposed to act as tumor suppressor genes, and several members have been implicated in the pathogenesis of a variety of human cancers. We examined p27Kip1 expression in 116 non-Hodgkin's lymphomas including 50 cases of MCL (40 typical and 10 blastic variants), 21 follicular lymphomas, 20 diffuse large B-cell lymphomas, 16 chronic lymphocytic leukemias, 8 marginal zone B-cell lymphomas, and 1 splenic marginal zone lymphoma, and correlated its expression with that of the proliferation marker Ki67 (MiB1) and with p53. p27Kip1 gene structure was analyzed by Southern blot in the group of MCLs. In all cases of non-Hodgkin's lymphoma other than MCL, p27Kip1 expression was inversely related to the proliferation index as measured by Ki67. In contrast, in typical MCL, p27Kip1 expression was negative in 35 of 40 (88%) cases, irrespective of the proliferative rate (median 15%; range 2 to 90%). Paradoxically, in the blastic variant of MCL, 8 of 10 (80%) cases showed expression of p27Kip1, despite a high proliferation rate (median 60%; range 32 to 100%). However, the staining in most of the cases was less intense than in the reactive T lymphocytes. Deletions of p27Kip1 gene were not found in any of the 25 cases examined. p53 expression was found in 15 of 50 cases of MCL: 7 of 10 (70%) in the blastic variant and 8 of 40 (20%) in the typical MCL (70% vs. 20%, P < 0.0045). These results demonstrate that MCLs, in contrast to other non-Hodgkin's lymphomas and normal lymphoid tissue, fail to correlate p27Kip1 expression with the proliferation rate. This peculiar uncoupling of p27Kip1 protein expression from the proliferation rate may be related to the high levels of cyclin D1 expressed in MCL and is likely to have profound effects on cell cycle regulation and contribute to the pathogenesis of MCL.
Insights
Mantle cell lymphomas (MCL) show a unique lack of correlation between p27Kip1 expression and cell proliferation, unlike other lymphomas. This uncoupling may drive MCL pathogenesis.
Area of Science:
- Cell Biology
- Oncology
- Molecular Biology
Background:
- p27Kip1 is a cyclin-dependent kinase inhibitor regulating cell cycle entry.
- Cyclin-dependent kinase inhibitors are implicated as tumor suppressors in various cancers.
- p27Kip1 levels influence cell cycle progression by interacting with cyclin complexes.
Purpose of the Study:
- To investigate p27Kip1 expression in non-Hodgkin's lymphomas, particularly mantle cell lymphoma (MCL).
- To correlate p27Kip1 expression with proliferation markers (Ki67) and p53 in MCL.
- To analyze p27Kip1 gene structure in MCL.
Main Methods:
- Examined p27Kip1 expression in 116 non-Hodgkin's lymphomas, including 50 MCL cases.
- Correlated p27Kip1 with Ki67 (proliferation) and p53 expression.
- Analyzed p27Kip1 gene structure by Southern blot in MCL.
Main Results:
- p27Kip1 inversely correlated with Ki67 in lymphomas, except MCL.
- Typical MCL showed negative p27Kip1 in 88% of cases, regardless of proliferation.
- Blastic MCL variant showed p27Kip1 expression in 80% despite high proliferation.
- p53 expression was higher in blastic MCL (70%) than typical MCL (20%).
- No p27Kip1 gene deletions were found.
Conclusions:
- MCL exhibits a distinct uncoupling of p27Kip1 expression from proliferation rate.
- This phenomenon may be linked to high cyclin D1 levels in MCL.
- The dysregulation of p27Kip1 likely contributes to MCL pathogenesis and cell cycle control.